Delhi High Court Rejects Themis Petition Against Ban of Diclofenac Injection - (09 Jul 2019)
LAW OF MEDICINE
Delhi High Court has rejected a petition filed by Themis Medicare challenging the ban imposed by the Drug Controller General of India on Diclofenac injection 75 mg/1ml marketed by its partner Novartis under Voveran 1ml brand.
Tags : DELHI HIGH COURT DICLOFENAC
Share :
|